Incyte (Nasdaq:INCY) announced today that it will present at the 11th Annual SVB Leerink Global Healthcare Conference (Virtual) on Thursday, February 17, 2022 at 11:20 a.m. ET.
The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow %40Incyte.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220203005010/en/